Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SIBN
stocks logo

SIBN

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
54.49M
+11.2%
-0.122
+11.36%
52.66M
+11.36%
-0.147
-1.91%
56.54M
+16.27%
-0.133
-5.1%
Estimates Revision
The market is revising Upward the revenue expectations for SI-BONE, Inc. (SIBN) for FY2025, with the revenue forecasts being adjusted by 1.09% over the past three months. During the same period, the stock price has changed by 18.11%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.09%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+18.11%
In Past 3 Month
Wall Street analysts forecast SIBN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SIBN is 22.60 USD with a low forecast of 20.00 USD and a high forecast of 26.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Analyst Rating
Wall Street analysts forecast SIBN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SIBN is 22.60 USD with a low forecast of 20.00 USD and a high forecast of 26.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
0 Hold
0 Sell
Strong Buy
Current: 19.240
sliders
Low
20.00
Averages
22.60
High
26.00
Current: 19.240
sliders
Low
20.00
Averages
22.60
High
26.00
Morgan Stanley
Overweight
maintain
$20 -> $23
2025-12-02
New
Reason
Morgan Stanley
Price Target
$20 -> $23
2025-12-02
New
maintain
Overweight
Reason
Morgan Stanley raised the firm's price target on SI-Bone to $23 from $20 and keeps an Overweight rating on the shares. Going into 2026, MedTech "looks well-positioned on several fronts" as the firm thinks major product cycles and a supportive hospital spending environment, combined with trough valuations, make for "a solid industry setup," the analyst tells investors in a note for the group on the upcoming year.
Truist
Richard Newitter
Buy
downgrade
$22 -> $20
2025-10-15
Reason
Truist
Richard Newitter
Price Target
$22 -> $20
2025-10-15
downgrade
Buy
Reason
Truist analyst Richard Newitter lowered the firm's price target on SI-Bone to $20 from $22 and keeps a Buy rating on the shares as part of a broader research note previewing Q3 results in MedTech. The firm expects "healthy" Q3 revenue and earnings across its coverage but also braces for "stock volatility", with new money feeling notably absent from the space, the analyst tells investors in a research note. Similar to Q2, specialist and fund positioning could be poised to drive excessive reactions on anything counter to crowded positioning, Truist states, adding that it is more inclined to be positive on "cleaner" names where there is less perceived controversy heading into the quarter.
Needham
David Saxon
Strong Buy
Reiterates
$19
2025-01-13
Reason
Needham
David Saxon
Price Target
$19
2025-01-13
Reiterates
Strong Buy
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for SI-BONE Inc (SIBN.O) is -37.01, compared to its 5-year average forward P/E of -18.12. For a more detailed relative valuation and DCF analysis to assess SI-BONE Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-18.12
Current PE
-37.01
Overvalued PE
-11.96
Undervalued PE
-24.28

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
50.95
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
392.06
Undervalued EV/EBITDA
-290.16

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
5.50
Current PS
0.00
Overvalued PS
7.95
Undervalued PS
3.05
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 1465.49% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areBuying! The buying amount has increased 457520.97% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 1465.49% over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

SIBN News & Events

Events Timeline

(ET)
2025-11-10
17:03:37
SI-Bone increases FY25 revenue forecast to $198M-$200M, up from $195M-$198M
select
2025-11-10
17:01:56
SI-Bone Announces Q3 Earnings Per Share of 11 Cents, Below Consensus Estimate of 17 Cents
select
2025-08-04 (ET)
2025-08-04
17:39:15
SI-Bone raises FY25 revenue view to $195M-$198M from $193.5M-$197.5M
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
1.0
11-19NASDAQ.COM
SI-BONE Scheduled to Present at Piper Sandler Annual Healthcare Conference Next Month

  • Company Presentation: SI-BONE, Inc. will present at the Piper Sandler 37th Annual Healthcare Conference on December 2, 2025, and recently reported a narrowed net loss of $4.6 million for Q3 2025.

  • Financial Performance: Total revenue for Q3 2025 increased by 19% to $48.7 million, with U.S. revenue rising 18% to $45.4 million, driven by strong demand for their products.

  • Product Highlights: The iFuse Bedrock Granite and TORQ TNT continue to be the main revenue-generating products for SI-BONE, contributing to the company's growth.

  • Future Outlook: SI-BONE anticipates fiscal year 2025 revenue between $190 million and $192 million, reflecting a positive growth trajectory compared to $167.2 million in fiscal year 2024.

[object Object]
Preview
9.5
11-11NASDAQ.COM
SI-BONE Inc. Reports Reduced Losses in Q3

  • Financial Performance: SI-BONE Inc. reported a loss of -$4.57 million for the third quarter, an improvement from -$6.58 million in the same period last year.

  • Earnings Per Share: The company's earnings per share (EPS) were -$0.11, compared to -$0.16 in the previous year.

  • Revenue Growth: Revenue increased by 20.6% to $48.66 million, up from $40.34 million year-over-year.

  • Future Guidance: SI-BONE Inc. provided full-year revenue guidance of $198 to $200 million.

[object Object]
Preview
4.0
10-15Benzinga
Truist Securities Reaffirms Buy Rating on SI-BONE, Adjusts Price Target to $20

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders, helping them stay informed and make timely decisions in the stock market.

  • Community of Traders: Over 10,000 serious traders are part of the Benzinga Pro community, benefiting from exclusive stories and insights provided by Benzinga reporters.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is SI-BONE Inc (SIBN) stock price today?

The current price of SIBN is 19.24 USD — it has increased 0.31 % in the last trading day.

arrow icon

What is SI-BONE Inc (SIBN)'s business?

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.

arrow icon

What is the price predicton of SIBN Stock?

Wall Street analysts forecast SIBN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SIBN is 22.60 USD with a low forecast of 20.00 USD and a high forecast of 26.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is SI-BONE Inc (SIBN)'s revenue for the last quarter?

SI-BONE Inc revenue for the last quarter amounts to 48.66M USD, increased 20.61 % YoY.

arrow icon

What is SI-BONE Inc (SIBN)'s earnings per share (EPS) for the last quarter?

SI-BONE Inc. EPS for the last quarter amounts to -0.11 USD, decreased -31.25 % YoY.

arrow icon

What changes have occurred in the market's expectations for SI-BONE Inc (SIBN)'s fundamentals?

The market is revising Upward the revenue expectations for SI-BONE, Inc. (SIBN) for FY2025, with the revenue forecasts being adjusted by 1.09% over the past three months. During the same period, the stock price has changed by 18.11%.
arrow icon

How many employees does SI-BONE Inc (SIBN). have?

SI-BONE Inc (SIBN) has 349 emplpoyees as of December 05 2025.

arrow icon

What is SI-BONE Inc (SIBN) market cap?

Today SIBN has the market capitalization of 832.24M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free